No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in western and west-central Africa: A four-year prospective multicenter study

Journal of Infectious Diseases

Volumn 186, Issue 4, 2002, Pages 486-492

  Laurent, Christian ^a   Bourgeois, Anke ^a,b   Faye, Mame Awa ^d   Mougnutou, Rose ^b   Seydi, Moussa ^d   Gueye, Mandoumbé ^e   Liégeois, Florian ^a   Touré Kane, Coumba ^f   Butel, Christelle ^a   Mbuagbaw, Josephine ^b   Zekeng, Léopold ^c   Mboup, Souleymane ^f   Mpoudi Ngolé, Eitel ^b   Peeters, Martine ^a   Delaporte, Eric ^a  

^a UNIV MONTPELLIER   (France)

^b Military Hospital   (Cameroon)

^c Laboratoire d Hygiène Mobile   (France)

^d Fann University Teaching Hospital   (United States)

^e Military Hospital   (United States)

^f Laboratory of Bacteriology and Virology   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; CAMEROON; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SENEGAL; STRAIN DIFFERENCE; SURVIVAL RATE; VIRUS STRAIN;

ADULT; CAMEROON; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RECOMBINATION, GENETIC; SENEGAL; SURVIVAL ANALYSIS;

EID: 0037103634     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/341833     Document Type: Article

References (27)

1. Genetic diversity of HIV-1: The moving target
2. Understanding the genetic diversity of HIV-1
3. Towards a better understanding of the epidemiology of HIV-2
4. Relationship between HIV-1 env subtypes A and D and disease progression in a rural Ugandan cohort
5. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D
6. Clinical disease associated with HIV-1 subtype B′ and E infection among 2104 patients in Thailand
7. Infection by different HIV-1 subtypes (B and C) results in a similar immune activation profile despite distinct immune backgrounds
8. Human immunodeficiency virus type 1 subtypes differ in disease progression
9. Various types of HIV mixed infections in Cameroon
10. Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence
11. Most env and gag subtypes A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG
12. The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon
13. Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes
14. CLUSTAL W. Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
15. Recombinant HIV sequences: Their role in the global epidemic
16. The neighbour-joining method: A new method for reconstructing phylogenetic trees
17. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequence
18. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
19. Marker paths
20. Is there a general tendency for CD4 lymphocyte decline to speed up during human immunodeficiency virus infection? Evidence from the Italian seroconversion study
21. What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective
22. Effect of ignoring the time of HIV seroconversion in estimating changes in survival over calendar time in observational studies: Results from CASCADE
23. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men
24. The Senegalese government's highly active antiretroviral therapy initiative: An 18-month follow-up study
25. Implementation of an antiretroviral (ART) program in Yasunde, Cameroon